Stay updated on ALRN-6924 in AML/MDS Safety Clinical Trial
Sign up to get notified when there's something new on the ALRN-6924 in AML/MDS Safety Clinical Trial page.

Latest updates to the ALRN-6924 in AML/MDS Safety Clinical Trial page
- CheckyesterdayChange DetectedUI text updates add Show glossary and Hide glossary options, a new 'Last Update Submitted that Met QC Criteria' label, and a 'Revision: v3.4.0' notice, while the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' labels were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check8 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedA consolidated 'Locations' section was added listing states (Colorado, Florida, New York, Oregon, South Carolina, Tennessee) and the separate 'State Locations' subsections were removed.SummaryDifference0.8%

- Check59 days agoChange DetectedRevision: v3.3.2 has been implemented, replacing v3.2.0. This update does not modify study details, eligibility criteria, or other user-relevant content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedThe funding/operational status banner was removed; the study details and other content remain unchanged.SummaryDifference0.4%

- Check81 days agoChange DetectedThe new screenshot shows only minor layout and styling tweaks with no changes to the study content or data. All sections and details remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to ALRN-6924 in AML/MDS Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALRN-6924 in AML/MDS Safety Clinical Trial page.